Technical Analysis for ADPT - Adaptive Biotechnologies Corporation

Grade Last Price % Change Price Change
A 5.31 9.71% 0.47
ADPT closed up 9.71 percent on Friday, November 1, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: Nov 7
*** please verify all earnings dates ***
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Overbought Stochastic Strength 0.00%
Fell Below 20 DMA Bearish 9.71%
MACD Bullish Centerline Cross Bullish 9.71%
Inside Day Range Contraction 9.71%
50 DMA Support Bullish 4.94%
Crossed Above 20 DMA Bullish 4.94%

   Recent Intraday Alerts

Alert Time
Up 10% about 16 hours ago
Up 1 ATR about 20 hours ago
Rose Above Previous Day's High about 20 hours ago
Up 5% about 20 hours ago
20 DMA Support about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Adaptive Biotechnologies Corporation Description

Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions that inform current and future clinical trials, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. It serves the life sciences research, clinical diagnostics, and drug discovery customers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Disease Infectious Diseases Drug Discovery Leukemia Blood Test Diagnostic Tests Blood Cancers Treatment Of A Range Of Cancer Residual Disease

Is ADPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.795
52 Week Low 2.28
Average Volume 958,431
200-Day Moving Average 3.89
50-Day Moving Average 4.72
20-Day Moving Average 4.85
10-Day Moving Average 4.75
Average True Range 0.31
RSI (14) 61.09
ADX 21.32
+DI 29.47
-DI 13.82
Chandelier Exit (Long, 3 ATRs) 4.87
Chandelier Exit (Short, 3 ATRs) 5.37
Upper Bollinger Bands 5.37
Lower Bollinger Band 4.34
Percent B (%b) 0.94
BandWidth 21.12
MACD Line 0.04
MACD Signal Line 0.01
MACD Histogram 0.0334
Fundamentals Value
Market Cap 768.74 Million
Num Shares 145 Million
EPS -1.36
Price-to-Earnings (P/E) Ratio -3.90
Price-to-Sales 3.18
Price-to-Book 1.51
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.05
Resistance 3 (R3) 5.97 5.65 5.92
Resistance 2 (R2) 5.65 5.46 5.69 5.88
Resistance 1 (R1) 5.48 5.35 5.57 5.56 5.84
Pivot Point 5.16 5.16 5.20 5.20 5.16
Support 1 (S1) 4.99 4.97 5.08 5.07 4.78
Support 2 (S2) 4.67 4.86 4.71 4.74
Support 3 (S3) 4.50 4.67 4.70
Support 4 (S4) 4.58